Bruce Michael Goodwin
CIK: 0002120535
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RADX
Radiopharm Theranostics Ltd
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Goodwin Bruce Michael
Goodwin Bruce Michael (SEC CIK 0002120535) files insider reports with the SEC as Director of Radiopharm Theranostics Ltd (RADX).
Signal8 holds 1 ownership filing by Goodwin Bruce Michael, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Goodwin Bruce Michael's filings is in CARLTON SOUTH, VICTORIA.
Other insiders filing for Radiopharm Theranostics Ltd (RADX)
- Voliotis Dimitris, Chief Medical Officer
- HOPPER PAUL, Director
- Donnelly Noel, Director
- Turner Ian Lawrence, Director